Nuzenio

Aclaris Therapeutics Inc

Aclaris Therapeutics Inc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 14 latest news signals 10 publisher sources 100/100 entity strength

Latest news

US FDA Fast-tracks Aclaris’ Modzatinib for Lichen Planus - The Dermatology DigestThe Dermatology Digest · Fri, 07 Aug 2026 15:34:47 GMT Aclaris Therapeutics, Inc. (ACRS) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Fri, 07 Aug 2026 13:08:53 GMT Craig-Hallum Maintains Aclaris Therapeutics(ACRS.US) With Buy Rating, Maintains Target Price $10 - MoomooMoomoo · Fri, 07 Aug 2026 07:54:52 GMT Aclaris Therapeutics (ACRS) Releases Q2 2026 Earnings: Revenue Declines, Losses Narrow - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 21:10:00 GMT Aclaris Therapeutics Receives Fast Track Designation for - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:35:00 GMT Aclaris Therapeutics (ACRS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:20:02 GMT Aclaris Therapeutics reports Q2 2026 net loss of $21.5M, cash runway through 2028 - TradingViewTradingView · Thu, 06 Aug 2026 11:23:02 GMT Aclaris: Q2 Earnings Snapshot - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 11:18:36 GMT

Timeline

Fri, 07 Aug 2026 15:34:47 GMTUS FDA Fast-tracks Aclaris’ Modzatinib for Lichen Planus - The Dermatology Digest

Fri, 07 Aug 2026 13:08:53 GMTAclaris Therapeutics, Inc. (ACRS) stock price, news, quote and history - Yahoo Finance UK

Fri, 07 Aug 2026 07:54:52 GMTCraig-Hallum Maintains Aclaris Therapeutics(ACRS.US) With Buy Rating, Maintains Target Price $10 - Moomoo

Thu, 06 Aug 2026 21:10:00 GMTAclaris Therapeutics (ACRS) Releases Q2 2026 Earnings: Revenue Declines, Losses Narrow - Quiver Quantitative

Thu, 06 Aug 2026 20:35:00 GMTAclaris Therapeutics Receives Fast Track Designation for - GlobeNewswire

Thu, 06 Aug 2026 12:20:02 GMTAclaris Therapeutics (ACRS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

ACRS14 live mentions Aclaris Therapeutics6 live mentions Therapeutics5 live mentions Yahoo Finance UK4 live mentions Aclaris3 live mentions Inc3 live mentions US FDA Fast2 live mentions Modzatinib2 live mentions Hallum Maintains Aclaris2 live mentions With Buy Rating2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Aclaris Therapeutics Inc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.